Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00915590 · ClinicalTrials.gov registry record · Phase 1
Topical IL-1-Ra for Treatment of Corneal Neovascularization
A Phase 1 study, sponsored by Reza Dana, MD.
- Terminated
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00915590: Clinical Trial Phase 1 study, sponsored by Reza Dana, MD.
NCT00915590 is a Phase 1 study that was terminated before completion, run by Reza Dana, MD. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00915590, a Phase 1 study, was terminated before completion, sponsored by Reza Dana, MD.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness and safety of Interleukin-1-Receptor Antagonist eye drops for the treatment of corneal blood vessels.
Primary Outcome
Incidence and severity of ocular adverse events, as identified by eye examination and visual acuity testing.
Interventions
- DRUG Placebo
- DRUG IL-1Ra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-04 |
| Est. Completion | 2011-03 |
| Phase | Phase 1 |
Why NCT00915590 stopped before completion
NCT00915590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00915590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00915590 about?
NCT00915590 is a clinical study titled "Topical IL-1-Ra for Treatment of Corneal Neovascularization". The purpose of this study is to determine the effectiveness and safety of Interleukin-1-Receptor Antagonist eye drops for the treatment of corneal blood vessels.
What is the current status of trial NCT00915590?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2009-04. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00915590?
The interventions under investigation include: Placebo (DRUG), IL-1Ra (DRUG).
Who is sponsoring clinical trial NCT00915590?
This trial is sponsored by Reza Dana, MD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00915590's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia